Integrating Molecular Profiling of Adrenocortical Carcinoma Into Clinical Practice
December 2nd 2021Processes used to identify and understand genetic markers detailing the prognosis and responsiveness to therapy in adrenocortical carcinoma (ACC) face a number of implementation barriers, limiting the potential for individualized ACC management.
Read More
Researchers Report Promising Strategy to Develop Personalized Therapy for Neuroblastoma
November 18th 2021Using cell cultures from pediatric patients with neuroblastoma, researchers performed drug-response testing and investigated correlations between copy number and cytotoxicity of drug treatment.
Read More